Related content

Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in β-Thalassemia Major Patients

By Elalfy Mohsen S.  

Hemoglobin, Vol. 37, Iss. 3, 2013-06 ,pp. : 257-276

Informa Healthcare

Access to resources Recommend Favorite

Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model

By Sørensen Michael  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 98-103

Informa Healthcare

Access to resources Recommend Favorite

Reproducibility of computed tomography angiography data analysis using semiautomated plaque quantification software: implications for the design of longitudinal studies

By Papadopoulou Stella-Lida  

The International Journal of Cardiovascular Imaging, Vol. 29, Iss. 5, 2013-06 ,pp. : 1095-1104

Springer Publishing Company

Access to resources Recommend Favorite

The Current Status of β-Thalassemia Major in Mainland China

By Xu Lu-Hong   Fang Jian-Pei  

Hemoglobin, Vol. 37, Iss. 4, 2013-08 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite

Mild β + -Thalassemia Associated With Two Linked Sequence Variants: IVS-II-839 (T>C) and IVS-II-844 (C>A)

By Waye John S.   Eng Barry   Hellens Laurie   Hohenadel Betty-Ann   Nakamura Lisa M.   Walker Lynda  

Hemoglobin, Vol. 37, Iss. 4, 2013-08 ,pp. : 378-386

Informa Healthcare

Access to resources Recommend Favorite